| 000 | 01000 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516034934.0 | ||
| 264 | 0 | _c20131114 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1537-453X | ||
| 024 | 7 |
_a10.1097/COC.0b013e318216e699 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDizon, Don S | |
| 245 | 0 | 0 |
_aWhere do antiangiogenic agents belong in the treatment algorithm for ovarian cancer? _h[electronic resource] |
| 260 |
_bAmerican journal of clinical oncology _cOct 2013 |
||
| 300 |
_a519-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 773 | 0 |
_tAmerican journal of clinical oncology _gvol. 36 _gno. 5 _gp. 519-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/COC.0b013e318216e699 _zAvailable from publisher's website |
| 999 |
_c20815560 _d20815560 |
||